Archives

by in
Entry Author Date Location
(Mis)Understanding Drug Discovery: It’s Much Harder Than Rocket Science 09/07/11 Seattle
Sanofi Collaboration Drives Regeneron’s Transformation From R&D House to Commercial Player 07/13/11 New York
Allozyne’s Backdoor IPO, Sound Pharma Fights iPod Deafness, Mirina Vs. Marina Ends, & More Seattle-Area Life Sciences News 06/23/11 Seattle
Pfizer Adds to Data on Novel RA Drug 04/28/11 New York
BG Medicine Chief Speaks on Rough IPO Climate, (Finally) Going Public 04/21/11 Boston
Pfizer Releases Top Line Data on Novel RA Drug 04/15/11 New York
Targeted Genetics, Re-invented as AmpliPhi, Bets on Anti-Bacterials, Moves HQ to London 03/09/11 Seattle
Diagnostics Are Warming Up in Era of Fast, Cheap Sequencing, Says MDV’s Rowan Chapman 02/07/11 San Francisco
Acceleron Pharma Cuts 40 Percent of Workforce 11/03/10 Boston
Via Science Forms to Launch “Big Data” Analytics Startups 11/02/10 Boston
Montgomery Joins Alder Board 11/01/10 Seattle
Amylin Regroups From FDA Smackdown, CalciMedica Plans Trial of New Anti-Immune Drug, FDA Gives CareFusion Recall Highest Priority, & More San Diego Life Science News 10/21/10 San Diego
CalciMedica Charges Ahead Toward First Human Test of Oral Pill for Psoriasis 10/20/10 San Diego
Rigel Nabs $25M From AstraZeneca 09/29/10 San Francisco
Rigel Arthritis Drug Passes Trial 09/23/10 San Francisco
Cytomx, Backed by Third Rock & Roche, Raises $30M for New Class of Antibodies 09/23/10 San Francisco
Glaxo’s Tempero Pharma Advances on Hot Niche of Immunology 07/15/10 Boston
Femta Pharmaceuticals Snags $2.2M for Potent Antibody Drugs 07/13/10 San Diego
Gilead Buys CGI for Up To $120M 06/25/10 San Francisco
Pfizer Dumps Trubion’s Lead Rheumatoid Arthritis Drug, Keeps Next-Gen Product Alive 06/14/10 Seattle
Biotech Drug Discovery in Seattle: A Look Back 06/11/10 Seattle
Alder, Bristol Arthritis Drug Shows “Outstanding” Results in Trial, Lead Researcher Says 05/17/10 Seattle
Alder Seeks to Treat Cancer in a Radical Way, Fighting Inflammation, Not Tumors 05/13/10 Seattle
Lycera Keeps Its Investors Happy, Snags $11M to Pursue New Autoimmune Drugs 04/28/10 Detroit
Innovation Northwest Wrapup: Alder, Tekmira, Acucela, & Other Emerging Little Biotechs 03/19/10 Seattle
Sage Bionetworks Strikes Deal With Pfizer to Find Cancer Drug Targets 01/11/10 Seattle
Alder Rival Wins FDA Approval 01/09/10 Seattle
Lycera, a Midwestern Biotech Star, Moves Head Office to Boston, Hires Biogen Vet as CEO 01/07/10 Boston
Alder Rises From Ashes of Layoffs to Become Seattle Biotech Force 01/04/10 Seattle
Alkermes Bets $10M on Long-Lasting Drug Technology from Startup Neighbor, Acceleron 12/03/09 Boston
Page 2 of 4 « previous page · next page »